A detailed history of Quest Partners LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 2,055 shares of VERA stock, worth $72,068. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,055
Previous 1,333 54.16%
Holding current value
$72,068
Previous $20.5 Million 332.21%
% of portfolio
0.02%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$14.91 - $49.14 $10,765 - $35,479
722 Added 54.16%
2,055 $88.6 Million
Q4 2023

Feb 09, 2024

BUY
$9.29 - $16.0 $12,383 - $21,328
1,333 New
1,333 $20.5 Million

Others Institutions Holding VERA

About Vera Therapeutics, Inc.


  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $948M
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.